Attenuation of neurologic injury during cardiac surgery

Annals of Thoracic Surgery

Volumn 72, Issue 5, 2001, Pages

  Murkin, John M ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; NIMODIPINE; PROPOFOL; THIOPENTAL;

AMNESIA; BRAIN EMBOLISM; CANNULATION; CLINICAL TRIAL; COMA; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART SURGERY; HUMAN; INTELLECTUAL IMPAIRMENT; META ANALYSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STROKE; STUPOR;

ANTI-INFLAMMATORY AGENTS; APROTININ; ARTERIOSCLEROSIS; BRAIN DISEASES; CARDIAC SURGICAL PROCEDURES; EMBOLISM; HUMANS; INFLAMMATION;

EID: 0035158858     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03258-1     Document Type: Conference Paper

References (61)

1. Adverse cerebral outcomes after coronary bypass surgery
2. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery
3. Long-term neurological and neuropsychological outcome 3 years after coronary artery bypass surgery
4. Cognitive change 5 years after CABG. Is there evidence of late decline?
5. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. II. Neurologic and cognitive outcomes
6. Etiology and incidence of brain dysfunction after cardiac surgery
7. Massive cerebral fat embolism from hip surgery: A histologic study with alkaline phosphatase staining and thick colloidin sections
8. Long-term cognitive dysfunction in the elderly ISPOCD1 study
9. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery
10. Thickened intima of the aortic arch is a risk factor for stroke with coronary artery bypass grafting
11. Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients
12. Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics
13. Cerebral emboli detected during bypass surgery are associated with clamp removal
14. Avoidance of embolic complications by ultrasonic characterization of the ascending aorta
15. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning
16. Significantly reduced incidence of stroke during coronary artery bypass grafting using transesophageal echocardiography
17. Transesophageal echocardiographic findings in subcortical and cortical stroke
18. Ultrasonic demonstration of manipulation-related aortic injuries after cardiac surgery
19. Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass
20. Strategy for the reduction of stroke incidence in cardiac surgical patients
21. Reduced neurological injury during CABG in patients with mobile aortic atheromas: A five-year follow-up study
22. The ascending aorta: How much does transesophageal echocardiography see?
23. The intraoperative assessment of ascending aortic atheroma: Epiaortic imaging is superior to both transesophageal echocardiography and direct palpation
24. Epiaortic scanning significantly alters surgical management during aortic instrumentation for cardiopulmonary bypass
25. Epiaortic scanning decreases cerebral emboli during aortic cannulation and application of partial occlusion clamp
26. The influence of epiaortic scanning on aortic cannulation for cardiac surgery
27. Management of the severely atherosclerotic ascending aorta during cardiac operations. A strategy for detection and treatment
28. Capture of particulate emboli during cardiac procedures in which aortic cross-clamp is used
29. Differential perfusion: A new technique for isolated brain cooling during cardiopulmonary bypass
30. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning
31. Brain microemboli during cardiac surgery or aortography
32. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass
33. Platelet and neutrophil activation in cardiopulmonary bypass
34. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons
35. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion
36. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans
37. Effect of aprotinin on neutrophil function after major vascular surgery
38. Does aprotinin inhibit cardiopulmonary bypass-induced inflammation?
39. An anti-inflammatory property of aprotinin discovered at the level of leukocyte extravasation
40. 2
41. Neuropsychiatric complications after cardiopulmonary bypass: Cerebral protection by a barbiturate
42. Effect of thiopental on neurologic outcome following coronary artery bypass grafting
43. Pharmacologic EEG suppression during cardiopulmonary bypass; cerebral hemodynamic, and metabolic effects of thiopental or isoflurane during hypothermia, and normothermia
44. Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction
45. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery
46. Nimodipine neuroprotection in cardiac valve replacement: Report of an early terminated trial
47. Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial
48. The relationship between reinfusion of shed blood and stroke in coronary artery bypass grafting patients
49. Effect of aprotinin (Trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass
50. Cardiopulmonary bypass and the inflammatory response: A role for serine protease inhibitors?
51. Full dose aprotinin administration is associated with a significant decrease in perioperative stroke in patients undergoing elective cardiac surgery
52. Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
53. Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study
54. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting
55. Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens
56. Analyses of coronary graft patency after aprotinin use: Results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial
57. Aprotinin: Safe and effective only with the full-dose regimen
58. Preliminary report of a genetic basis for cognitive decline after cardiac operations
59. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization